As Clinics Providing Abortions Closed in Iowa, STD Rates Started Rising
Even before the U.S. Supreme Court overturned Roe v. Wade last summer, many states had already moved to limit abortion access by defunding family planning health centers.
Unfortunately, these very same clinics offer a broad range of essential primary care services beyond abortion, including access to sexually transmitted infection (STI) screening and treatment.
Now, a new study uncovers the potential fallout of closing those centers: Researchers found dramatically higher rates of both gonorrhea and chlamydia across Iowa right after the passage of a statewide defunding law back in 2017.
“So many patients seeking care in these clinics are looking for services not related to abortion care,” explained study author Dr. Megan Srinivas, an infectious disease clinical instructor and translational health policy research fellow at the University of North Carolina's Institute for Global Health and Infectious Disease, in Chapel Hill.
“Many of these clinics provided STI gonorrhea and chlamydia counseling, testing, treatment and prevention services that were not related to the abortion issue that the Iowa legislature targeted,” Srinivas explained. “Thus, we looked to see if STI rates increased in the areas of clinic closures, compared to unaffected areas in Iowa.”
After crunching the numbers, she and her team found they had.
Analyzing data collected by the U.S. Centers for Disease Control and Prevention, the investigators found that between 2016 and 2018, the state's rate of gonorrhea infection nearly doubled, rising from 83 cases to 154 cases for every 100,000 Iowans. The statewide chlamydia rate also rose, from 415 cases to 466 cases for every 100,000 Iowans.
The research team further determined that the rise in STI risk occurred both very quickly after passage of the defunding legislation and "in the specific locations of clinic closures."
And Srinivas added that while her team's analysis can only show an association between the timing of defunding legislation, clinic closures and infection rates, "it does create concern that legislation targeting abortion providers can be having unintended negative impacts on care, and more rapidly than we would have suspected.”
The findings come as sexually transmitted infection rates continue to hit new highs in the United States. In 2020, the latest year for which statistics are available, nearly 2.4 million Americans had chlamydia, gonorrhea or syphilis, CDC data shows.
Looking ahead, Srinivas said the findings suggest that legislators in other states who are considering similar legislation should “carefully look at the other services these clinics provide before executing defunding mechanisms."
“In a place like Iowa, where the policy has already been instituted, reversal would be ideal,” she noted. “In the meantime, intermediary steps such as introducing point-of-care testing at alternative sites, like pharmacies, can be considered,” alongside efforts to broaden access to telemedicine options, and ensure that alternative care options are affordable.
The findings were published online Oct. 14 in JAMA Network Open.
Dr. Philip Tierno Jr. is a professor of microbiology and pathology with the NYU School of Medicine in New York City.
While not involved in the study, he showed little surprise that family planning clinic closures caused increased sexually transmitted diseases (STDs).
That's because such “clinics also provide a convenient avenue to get information on STDs as well as an easy access to answer questions that they wouldn't or couldn't ask their personal physician, or simply provide advice to people above and beyond family planning,” Tierno noted.
As to what could be done, Tierno said that one practical solution would be the establishment of free-of-cost Department of Health testing stations precisely in those communities that are most affected by new abortion restriction laws.
There's more on abortion restriction legislation at the Guttmacher Institute.
SOURCES: Megan Srinivas, MD, MPH, infectious disease clinical instructor and translational health policy research fellow, University of North Carolina Institute for Global Health and Infectious Disease, Chapel Hill, N.C.; Philip M. Tierno, Jr., MD, PhD, professor, microbiology and pathology, NYU School of Medicine, NYU Langone Medical Center, New York City; JAMA Network Open, Oct.14, 2022, online